ERBB2 and breast cancer: According to studies, BIRC5 (survivin), an inhibitor of apoptosis (IAP) family member was substantially expressed in BC patients and, it also promotes resistance to chemotherapy, anti-HER2 treatment, and radiotherapy [59].